Zhou Lihan
Algemeen Directeur bij MiRXES Pte Ltd.
Profiel
Zhou Lihan is the founder of Ark Bio Holding Pte Ltd.
(founded in 2018) and Mirxes Holding Co., Ltd.
(founded in 2014).
He holds the title of Co-Chief Executive Officer & Director at Ark Bio Holding Pte Ltd.
and Chief Executive Officer & Executive Director at Mirxes Holding Co., Ltd.
Currently, Dr. Lihan is the Chief Executive Officer at MiRXES Pte Ltd.
since 2014.
Dr. Lihan's education includes an undergraduate degree from the National University of Singapore in 2007 and a doctorate degree from Yong Loo Lin School of Medicine in 2012.
Actieve functies van Zhou Lihan
Bedrijven | Functie | Begin |
---|---|---|
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Algemeen Directeur | 01-09-2017 |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | Oprichter | 01-01-2018 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Oprichter | 01-05-2014 |
Opleiding van Zhou Lihan
National University of Singapore | Undergraduate Degree |
Yong Loo Lin School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Commercial Services |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | Finance |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Finance |